
Safety data sheet
Standardized safety protocols and material specifications for professional use.
Certificate of Analysis
Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-sermorelin-injection-pen-5mg
Sermorelin Acetate Injection Pen (5mg)
High >98% Purity
Authorized Resellers
Available through our trusted partners
123peptide.com
Netherlands · Europe
local_shipping2-3 Business Days
Depeptidenwinkel.com
Netherlands · Europe
local_shipping2-3 Business Days
Scientific Background
Intended Research Use
- GHRH receptor activation and pituitary GH stimulation research
- Age-related GH decline and IGF-1 restoration studies
- Body composition — lean mass gain and fat metabolism research
- Sleep architecture and energy restoration studies
- Physiologic hormone optimization with preserved feedback loops
menu_bookScientific Publications
Paediatr Drugs (1999)
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/10913299/
Clin Interv Aging (2006)
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/18047278/
J Clin Endocrinol Metab (2008)
Growth hormone-releasing hormone effects on cognition in healthy older adults
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/17911170/
Endocrinol Metab Clin North Am (2005)
Growth hormone-releasing hormone and growth hormone secretagogues in normal aging
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/15826933/
FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.
Possible stacks with other peptides
Synergistic combinations for enhanced research outcomes
Sermorelin's GHRH activity pairs powerfully with GH secretagogues and metabolic peptides for amplified and sustained GH release.

Ipamorelin 5mg Pen (5mg vial)
arrow_forwardmyo-ipamorelin-injection-pen-5mg
Classic GHRH + GHRP synergy — Sermorelin activates GHRH receptors while Ipamorelin activates ghrelin/GHS receptors for amplified, complementary pulsatile GH release.

CJC-1295 (no DAC) (2mg vial)
arrow_forwardmyo-cjc-1295-no-dac-2mg
Prolonged GHRH stimulation alongside Sermorelin for extended anabolic GH pulses and enhanced IGF-1 output.

AOD-9604 5mg (5mg vial)
arrow_forwardmyo-hgh-fragment-aod-9604-5mg
Targeted fat reduction alongside Sermorelin's systemic GH stimulation for comprehensive body composition research.
Cycling Note: Typical protocol: 3–6 months continuous with 4-week rest. Monitor IGF-1 at 6–8 week intervals.
